l 012 has been researched along with aldosterone in 1 studies
| Studies (l 012) | Trials (l 012) | Recent Studies (post-2010) (l 012) | Studies (aldosterone) | Trials (aldosterone) | Recent Studies (post-2010) (aldosterone) |
|---|---|---|---|---|---|
| 24 | 0 | 10 | 25,333 | 1,517 | 4,169 |
| Protein | Taxonomy | l 012 (IC50) | aldosterone (IC50) |
|---|---|---|---|
| Mineralocorticoid receptor | Homo sapiens (human) | 0.0048 | |
| Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | 0.043 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chrissobolis, S; Drummond, GR; Faraci, FM; Sobey, CG | 1 |
1 other study(ies) available for l 012 and aldosterone
| Article | Year |
|---|---|
Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation.
Topics: Age Factors; Aldosterone; Animals; Blood Pressure; Cardiovascular Diseases; Cerebral Arteries; Cerebrovascular Circulation; Endothelium, Vascular; Luminol; Male; Membrane Glycoproteins; Mice; NADPH Oxidase 2; NADPH Oxidases; Reactive Oxygen Species; Risk Factors; Superoxides | 2014 |